Current Role of Leukotriene Receptor Antagonists in Preschool Asthma

Silvia      Montella; Sara      De Stefano; Marco      Maglione; Angela   Di   Giorgio; Virginia      Mirra; Claudio      Pignata; Mariacarolina      Salerno; Francesca      Santamaria

doi:10.2174/157339812803832502

Abstract

Asthma in preschool children is common. One in three children has at least one episode of wheezing prior to their third birthday, and the cumulative prevalence of wheeze is almost 50% at the age of 6 years. The management of these patients, especially when symptoms are recurrent and severe, is a challenging task. Clinical benefits of inhaled corticosteroids in preschool asthmatic children are still controversial. Since leukotrienes are potent bronchoconstrictive agents, the leukotriene receptor antagonists (LTRAs) are used in asthmatic patients to inhibit their action in the respiratory tract. Montelukast, the only LTRA approved for young children use in several countries, is also known to have antieosinophilic properties. This review summarizes the most recent evidence on the role of LTRAs, particularly montelukast, in the treatment of preschool asthma. Montelukast seems to be effective in preschool asthma and recurrent wheezing for improving symptoms, lung function, and bronchial inflammation, and for protecting against cold air-induced bronchial hyperreactivity. The scarce data available do not allow to reach definitive conclusions on LTRAs efficacy in acute asthma or in the obese-asthma phenotype. The excellent safety profile of montelukast and the convenience of oral delivery, that entail better compliance from young children, represent the main strengths of its use in preschool children. LTRAs represent a valid alternative to inhaled corticosteroids in young children, and are suggested mainly to reduce virus-induced exacerbations, to overcome the difficulties due to the inhaled therapy, in subjects showing adverse effects related to long-term steroid therapy, or when compliance is poor.

Keywords: Asthma, leukotriene receptor antagonists, leukotrienes, montelukast, preschool children, wheezing.

« Previous Next »